Maralixibat
SHP625-306
Phase 3 small_molecule terminated
Quick answer
Maralixibat for Progressive Familial Intrahepatic Cholestasis (PFIC) is a Phase 3 program (small_molecule) at Mirum Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Progressive Familial Intrahepatic Cholestasis (PFIC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated